Literature DB >> 19485745

Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges.

Timothy F Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19485745     DOI： 10.1586/erv.09.28

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  11 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.

Authors:  Antonia C Perez; Antoinette Johnson; Ziqiang Chen; Gregory E Wilding; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Authors:  Jeremiah J Davie; Josh Earl; Stefan P W de Vries; Azad Ahmed; Fen Z Hu; Hester J Bootsma; Kim Stol; Peter W M Hermans; Robert M Wadowsky; Garth D Ehrlich; John P Hays; Anthony A Campagnari
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

4.  Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.

Authors:  Min Yang; Antoinette Johnson; Timothy F Murphy
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

5.  Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.

Authors:  Dabin Ren; Shengqing Yu; Song Gao; Daxin Peng; Ronald S Petralia; Artur Muszynski; Russell W Carlson; John B Robbins; Chao-Ming Tsai; David J Lim; Xin-Xing Gu
Journal:  Vaccine       Date:  2011-04-16       Impact factor: 3.641

Review 6.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 7.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

8.  Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract.

Authors:  Timothy F Murphy; Aimee L Brauer; Charmaine Kirkham; Antoinette Johnson; Mary Koszelak-Rosenblum; Michael G Malkowski
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

9.  Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.

Authors:  Taketo Otsuka; Charmaine Kirkham; Antoinette Johnson; Megan M Jones; Timothy F Murphy
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

10.  Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.

Authors:  Margarita Smidt; Patrick Bättig; Suzanne J C Verhaegh; Axel Niebisch; Markus Hanner; Sanja Selak; Wolfgang Schüler; Eva Morfeldt; Christel Hellberg; Eszter Nagy; Urban Lundberg; John P Hays; Andreas Meinke; Birgitta Henriques-Normark
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.